Ancient Plant ( Hoodia
) Promises to Make New Fortunes From the Overweight
With the discovery of the molecule P57, found in
Hoodia Gordonii,
drug and food companies are scrambling to capitalize on its
benefits. P-57 works as an amazing appetite suppressant by mimicking
the effect glucose has on the brain and tricking your body into
thinking it's full.
Drug companies,
eager to tap into the multi-billion dollar diet industry, are now in
the process of developing a multitude of products to cash in on
Hoodia Gordonii's ancient
benefits.
Pfizer, a
well-known company has big plans for P57. They are now testing and
developing a prescription diet drug, which will utilize P57. Current
estimates state that their drug will be available on the market by
2008, provided that it passes FDA approval.
Unilever, the maker
of Slimfast, plans to integrate P-57 into their diet shakes in an
effort to further capitalize on this market. Slimfast already
produces revenues in excess of $1.3 billion annually, a figure that
is anticipated to increase significantly with the introduction of
P57 into their shakes.
Phytopharm, a
European company has already benefited from P57 by selling the
rights to Pfizer for $13 million. They are now in the process of
attempting to raise
Hoodia
Gordonii on a massive scale on a plantation at a secret
location in Southern Africa. If they are successful in
mass-producing the notoriously hard to cultivate Hoodia plant, they
stand to gain 5% of the profits produced by the sale of prescription
drugs.
The
popularity and promise of
Hoodia
Gordonii
has sparked a rash of pirates, people who try to sneak into the
desert and steal the plants, which are illegal to export at this
time. Experts think that
Hoodia
Gordonii
will easily surpass another Pfizer product, Viagra, in popularity,
and sales, which is no easy feat. |
